Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Braunstein Scott
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hulihan Joseph
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MANNING MARTHA E
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shafer Christina
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pfanstiel Steven
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.4%)
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Silverstein Christine Berni
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Austin Charles
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shafer Christina
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Johnson Marvin
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Nochur Sara
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MAYLEBEN TIMOTHY M
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Noonberg Sarah B.
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fischer Seth H. Z.
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ezickson Elan
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Braunstein Scott
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pfanstiel Steven
No Data
No Data